BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 5, 2011
View Archived Issues
Zealand Pharma presents new preclinical data on ZP-3022 and ZP-2929 in models of diabetes/obesity
Read More
AN-6414 is safe and improves symptoms of arthritis in preclinical studies
Read More
Cannabinoid CB1 receptor inverse agonist JD-5037 has no effects on CNS
Read More
Advinus Therapeutics and Merck & Co. discover new small-molecule SUCNR1 receptor antagonist
Read More
AR-00472159 has anti-inflammatory activity in mice with experimental colitis
Read More
Linagliptin approved in Japan for type 2 diabetes
Read More
NeuroSearch provides update on planning of phase III program for Huntexil in Huntington's disease
Read More
Novel free fatty acid FFA2 receptor agonists patented by Euroscreen
Read More
Merck KGaA files with EMA to extend Rebif indication to patients with early signs of MS
Read More
Unversity of Georgia presents new HIV integrase inhibitors
Read More
Japanese marketing approval granted for Betanis for overactive bladder
Read More
Targacept claims new nicotinic acetylcholine alpha4beta2 receptor ligands
Read More
Janssen obtains Japanese manufacturing and marketing license for Simponi in RA
Read More
Roche and Siena Biotech present novel beta-secretase inhibitors
Read More
Takeda receives Japanese approval for Liovel NDA in type 2 diabetes
Read More
Medivir and Meda renegotiate terms of commercial partnership for Xerese
Read More
Researchers at Shionogi disclose new beta-secretase 1 inhibitors
Read More
Lantheus initiates phase III trial of PET imaging with flurpiridaz F-18 for CAD
Read More
FDA accepts for filing Corcept Therapeutics' Corlux NDA for Cushing's syndrome
Read More
Ono Pharmaceutical's Corebeta approved in Japan to improve quality of coronary CT angiography images
Read More
Novartis halts phase III study of Afinitor in advanced breast cancer after meeting primary endpoint
Read More
ALK-Abello provides update on North American allergy vaccine partnership with Merck & Co.
Read More
Antisense Therapeutics grants exclusive option to license anticancer compound ATL-1101 to Afandin
Read More
Medicago reports encouraging phase II results on H5N1 vaccine
Read More
FDA grants Advaxis pre-IND meeting for prostate cancer immunotherapy Advaxis PSA
Read More
